|
Human Genome Sciences Announces Fourth-Quarter and Full-Year Financial ... - EON: Enhanced Online News (press release)
Wed, 19 Jun 2013 17:52“2010 was a pivotal year in Human Genome Sciences' progress toward becoming a fully commercial organization with sustainable revenues and growth,” said H. Thomas Watkins, President and Chief Executive Officer. “The FDA Arthritis Advisory Committee ...
|
|
Human genome project paid off in $966 B life sciences boom - The News Journal
Sun, 16 Jun 2013 09:34Sophie Liu, research scientist at Complete Genomics Inc., works in the sequencing center at the company's research facility in Mountain View, Calif., in 2011. A decade ago, sequencing a single human genome took the combined efforts of laboratories and ...
|
|
Human Genome Project Spurred $966 Billion Sciences Boom - Bloomberg
Wed, 12 Jun 2013 19:08The $14.5 billion investment by the U.S. in the Human Genome Project, completed a decade ago, has paid off more than 60-fold in new jobs, drugs and a rapidly expanding genetics industry, an analysis has found. The endeavor to map human DNA in its ...
|
|
Human Genome Sciences and Lonza Enter Commercial Manufacturing ... - EON: Enhanced Online News (press release)
Mon, 10 Jun 2013 21:57ROCKVILLE, Md. & BASEL, Switzerland--(EON: Enhanced Online News)--Human Genome Sciences, Inc. (Nasdaq:HGSI) and Lonza today announced an agreement for the future commercial supply of BENLYSTA® (belimumab), which is currently under ...
|
|
McCaskill Demands Answers On $334 Million Anthrax Program - KTTS
Wed, 19 Jun 2013 21:47Since 2006, the government has spent approximately $334 million to purchase more than 65,000 doses of raxibacumab from Human Genome Sciences, Inc. Raxibacumab is the only available anthrax antitoxin on the market. It costs more than $5,000 per ...
|
|
Selling an Anthrax Scare? - Scientist
Tue, 21 May 2013 12:00The company, Human Genome Sciences, made $334 million selling the anthrax antitoxin raxibacumab to its sole customer, the federal government, at $5,100 per dose. Human Genome Sciences paid Danzig at least $1 million in director's fees and stocks ...
|
|
School of Medicine announces plans for new research building - Washington University in St. Louis News
Wed, 19 Jun 2013 19:09Article Body 2010. Washington University School of Medicine in St. Louis plans to construct an energy-efficient, multistory research building dedicated to interdisciplinary research on some of the most complex problems in human biology. ... The ...
|
|
Gene patent ruling irks some experts - Duke Chronicle
Thu, 20 Jun 2013 02:52Myriad Genetics that it is not lawful to patent naturally occurring human genomes, even if they are engineered to be isolated. Myriad, a molecular diagnostic company, patented the genes BRCA1 and BRCA2 after isolating them several years ago. ... Misha ...
|
|
How Ashkenazi are you? Tapping into genetic secrets online - Haaretz
Tue, 18 Jun 2013 16:28“I think people are attracted by this idea of being part of a lost tribe,” said Misha Angrist, an assistant professor at the Duke Institute for Genome Sciences and Policy and the author of the 2010 book “Here Is a Human Being: At the Dawn of Personal ...
|
|
What Do Memories Look Like? - Science Daily (press release)
Wed, 19 Jun 2013 17:16The new research could offer crucial insight for scientists responding to President Barack Obama's Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative, which was announced in April. Modeled after the Human Genome Project ...
|
|
Supreme Court Invalidated Gene Patents: What's Next? - PR Newswire (press release)
Wed, 19 Jun 2013 18:10Mary-Claire King, PhD, is American Cancer Society professor in the Department of Medicine and the Department of Genome Sciences at the University of Washington in Seattle, Washington. ... She pioneered the use of DNA sequencing for human rights ...
|
|
Supreme Court Invalidated Gene Patents: What's Next? Media Are Invited to ... - Newswise (press release)
Wed, 19 Jun 2013 18:45Mary-Claire King, PhD, is American Cancer Society professor in the Department of Medicine and the Department of Genome Sciences at the University of Washington in Seattle, Washington. She was the first to prove that breast cancer is inherited in some ...
|
|
Biotech moves on as top US court invalidates patents - BusinessWorld Online Edition
Mon, 17 Jun 2013 16:05Keeping a company afloat based on basic gene patents will now be more difficult, if not impossible, said Wales, a former employee of Human Genome Sciences, one of the largest gene-patent holders, which was acquired by pharmaceutical giant ...
|
|
BREAKING: Monsanto, Syngenta Executives Honored As 2013 World Food ... - CropLife
Wed, 19 Jun 2013 18:37The World Food Prize is the foremost international award recognizing – without regard to race, religion, nationality, or political beliefs – the achievements of individuals who have advanced human development by improving the quality, quantity or ...
|
|
Genetics of cervical cancer raise concern about antiviral therapy in some cases - HealthCanal.com
Wed, 19 Jun 2013 22:25The analysis provides a clearer picture of the chromosomal and genetic changes that take place as the human papillomavirus sometimes leads to chronic infection and, in less than 1 percent of cases, to cervical cancer. It is the first to identify ...
|
